Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yunxing Cheng
Institution:
Pharmaron (China)
Observed institution:
Pharmaron (China)
OpenAlex ID:
A5111106973
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
2024
·
Michael Berlin
, Jennifer Cantley
, et al.
·
Journal of Medicinal Chemistry
·
43
Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib
2025
·
Qinying Yu
, Li Ma
, et al.
·
Journal of Medicinal Chemistry
·
10
Correction to “PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models”
2025
·
Michael Berlin
, Jennifer Cantley
, et al.
·
Journal of Medicinal Chemistry
Show more works
View as search
Works count:
3
Citation count:
53
H-index:
2
I10-index:
2
Year
Topic
Type
